Free. Unsubscribe any time.
Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. filed 25 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 35 transactions and 381,540 shares. 10 carry the SEC's AFF10B5ONE flag; 15 name a plan only in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-07, came 19 days after the one before it (2026-06-18) and reports 1 transaction against 2 in the filing before it.
- The sales it reports total 3,000 shares, 3,900 fewer than the 6,900 in the filing before it.
- Its 25 plan statements rank 243rd of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 25 filings on file run from 2025-01-07 to 2026-07-07, and state 7 plan adoption dates, from 2024-08-30 to 2025-12-12.
Trades in Crinetics Pharmaceuticals, Inc. 35
- Pizzuti Dana — 2025-01-03 · S · 15,000 shares
- Pizzuti Dana — 2025-02-03 · S · 5,000 shares
- Betz Stephen F. — 2025-03-19 · S · 5,479 shares
- Betz Stephen F. — 2025-03-19 · S · 291 shares
- Knight Jeff E. — 2025-03-19 · S · 6,801 shares
- Knight Jeff E. — 2025-03-19 · S · 361 shares
- Pizzuti Dana — 2025-03-19 · S · 2,388 shares
- Pizzuti Dana — 2025-03-19 · S · 127 shares
- Struthers Richard Scott — 2025-03-19 · S · 16,463 shares
- Struthers Richard Scott — 2025-03-19 · S · 875 shares
- Betz Stephen F. — 2025-06-12 · S · 97,483 shares
- Pizzuti Dana — 2025-08-20 · S · 6,492 shares
Adoption dates in Crinetics Pharmaceuticals, Inc. 7
- 2024-08-30 — stated in 1 filing
- 2024-12-03 — stated in 1 filing
- 2025-05-21 — stated in 6 filings
- 2025-06-07 — stated in 1 filing
- 2025-11-19 — stated in 2 filings
- 2025-12-11 — stated in 2 filings
- 2025-12-12 — stated in 1 filing
Results prints in Crinetics Pharmaceuticals, Inc. 9
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-01-05
- 2026-01-13
- 2026-02-26
- 2026-05-07
- 2026-08-03
Trades before a print in Crinetics Pharmaceuticals, Inc. 3
- 0 days before the 2026-01-05 print — 2026-01-05 · S · Kalofonos Isabel · 2,500 shares
- 3 days before the 2025-11-06 print — 2025-11-03 · S · Pizzuti Dana · 4,900 shares
- 3 days before the 2025-11-06 print — 2025-11-03 · S · Pizzuti Dana · 100 shares
- 24 days before the 2025-02-27 print — 2025-02-03 · S · Pizzuti Dana · 5,000 shares
- 29 days before the 2026-05-07 print — 2026-04-08 · S · Knight Jeff E. · 85,163 shares
- 32 days before the 2026-08-03 print — 2026-07-02 · S · Vivaldi Coelho Rogerio · 3,000 shares
- 35 days before the 2026-01-05 print — 2025-12-01 · S · Pizzuti Dana · 5,000 shares
- 36 days before the 2025-11-06 print — 2025-10-01 · S · Pizzuti Dana · 5,000 shares
- 41 days before the 2025-11-06 print — 2025-09-26 · S · Fust Matthew K · 16,000 shares
- 41 days before the 2025-11-06 print — 2025-09-26 · S · Struthers Richard Scott · 4,000 shares
- 47 days before the 2026-08-03 print — 2026-06-17 · S · Okey Stephanie · 6,292 shares
- 47 days before the 2026-08-03 print — 2026-06-17 · S · Okey Stephanie · 608 shares
Interval to Crinetics Pharmaceuticals, Inc.’s next reported results date
How the interval and sources are counted →
- 3within 5 days
- 3within 10 days
- 0shortest, days
- 0no later print
- Pizzuti Dana 2025-11-03 · S · 3 days before the 2025-11-06 print · Chief Med and Dev Officer
- Pizzuti Dana 2025-11-03 · S · 3 days before the 2025-11-06 print · Chief Med and Dev Officer
- Kalofonos Isabel 2026-01-05 · S · 0 days before the 2026-01-05 print · Chief Commercial Officer
Adoption dates Crinetics Pharmaceuticals, Inc. states
- 2024-08-30 in 1 filing
- 2024-12-03 in 1 filing
- 2025-05-21 in 6 filings
- 2025-06-07 in 1 filing
- 2025-11-19 in 2 filings
- 2025-12-11 in 2 filings
- 2025-12-12 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on May 21, 2025”
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-01-05
- 2026-01-13
- 2026-02-26
- 2026-05-07
- 2026-08-03
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.